3M CO Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
3M CO (MMM) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $49.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2026-02-03
- 3M CO unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2025 was $49.00M, a 36.11% increase from fiscal 2024.
- 3M CO unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2024 was $36.00M, a 14.29% decline from fiscal 2023.
- 3M CO unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2023 was $42.00M, a 31.25% increase from fiscal 2022.
- 3M CO unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2022 was $32.00M, a 15.79% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month as first filed |
|---|---|---|
| 2025-12-31 | $49.00M 10-K · filed 2026-02-03 | |
| 2024-12-31 | $36.00M 10-K · filed 2026-02-03 | |
| 2023-12-31 | $42.00M 10-K · filed 2026-02-03 | $114.00M 10-K · filed 2024-02-07 |
| 2022-12-31 | $32.00M 10-K · filed 2025-02-05 | $39.00M 10-K · filed 2023-02-08 |
| 2021-12-31 | $38.00M 10-K · filed 2024-02-07 | |
| 2020-12-31 | $53.00M 10-K · filed 2023-02-08 | |
| 2019-12-31 | $24.00M 8-K · filed 2022-04-26 | |
| 2018-12-31 | $18.00M 10-K · filed 2021-02-04 | |
| 2017-12-31 | $16.00M 10-K · filed 2020-02-06 | |
| 2016-12-31 | $11.00M 10-K · filed 2019-02-07 | |
| 2015-12-31 | $16.00M 8-K · filed 2018-05-08 | |
| 2014-12-31 | $79.00M 8-K · filed 2017-05-04 | |
| 2013-12-31 | $78.00M 8-K · filed 2016-05-17 | |
| 2012-12-31 | $90.00M 10-K · filed 2015-02-12 | |
| 2011-12-31 | $75.00M 8-K · filed 2014-05-15 | |
| 2010-12-31 | $54.00M 10-K · filed 2012-02-16 | |
| 2009-12-31 | $47.00M 10-K · filed 2012-02-16 | |
| 2008-12-31 | $66.00M 8-K · filed 2011-05-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |